Identification of 16S rRNA Methylase-Producing Acinetobacter baumannii Clinical Strains in North America-Reference-Cited by-同舟云学术

Identification of 16S rRNA Methylase-Producing Acinetobacter baumannii Clinical Strains in North America

Published:2007-11 Issue:11 Volume:51 Page:4209-4210
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Doi Yohei¹,Adams Jennifer M.¹,Yamane Kunikazu²,Paterson David L.¹³⁴

Affiliation:

1. Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

2. Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo, Japan

3. University of Queensland, Brisbane, Australia

4. Queensland Health Pathology Services, Royal Brisbane and Women's Hospital, Brisbane, Australia

Abstract

ABSTRACT Five highly amikacin-resistant Acinetobacter baumannii isolates were collected at a medical center in Pennsylvania. The aminoglycoside resistance was due to the production of the 16S rRNA methylase ArmA. Two of the isolates coproduced OXA-23 β-lactamase and were highly resistant to carbapenems as well. The isolates were genetically closely related by pulsed-field gel electrophoresis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00560-07

Reference16 articles.

1. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

2. Bonomo, R. A., and D. Szabo. 2006. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis.43(Suppl. 2):S49-S56.

3. Bouchillon, S. K., D. J. Hoban, B. M. Johnson, J. L. Johnson, A. Hsiung, and M. J. Dowzicky. 2005. In vitro activity of tigecycline against 3989 gram-negative and gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). Diagn. Microbiol. Infect. Dis.52:173-179.

4. Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis.45:88-94.

5. Sequence Analysis of ARI-1, a Novel OXA β-Lactamase, Responsible for Imipenem Resistance in Acinetobacter baumannii 6B92

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review;Osong Public Health and Research Perspectives;2023-10-31

2. Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex;Clinical Infectious Diseases;2023-05-01

3. Multidrug-Resistant Acinetobacter baumannii: An Emerging Aspect of New Drug Discovery;Recent Advances in Anti-Infective Drug Discovery;2023-03-23

4. Acinetobacter baumannii: Emergence of a Superbug, Past, Present, and Future;The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions;2022-09-14

5. The First Saudi Study Investigating the Plasmid-borne Aminoglycoside and Sulfonamide Resistance among Acinetobacter baumannii Clinical Isolates Genotyped by RAPD-PCR: the Declaration of a Novel Allelic Variant Called aac(6ʹ)-SL and Three Novel Mutations in the sul1 Gene in the Acinetobacter Plasmid (s);Infection and Drug Resistance;2021-11